Article Details

NiKang licenses drug in China for $15M - Delaware Business Times

Retrieved on: 2022-05-03 21:13:27

Tags for this article:

Click the tags to see associated articles and topics

NiKang licenses drug in China for $15M - Delaware Business Times. View article details on hiswai:

Excerpt

WILMINGTON – The private biopharmaceutical startup NiKang Therapeutics ... NiKang has quietly become one of the most intriguing biopharma startups ...

Article found on: delawarebusinesstimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up